A multiple dose powder inhaler (Turbuhaler) compared with a conventional aerosol. An acceptance study in asthmatics.
Nineteen patients with asthma completed an open, randomized, crossover study in which 0.5 mg terbutaline sulphate was administered either via Turbuhaler or via the metered dose inhaler (MDI) for 2-week periods. The clinical effect of the two treatment forms was comparable; both provided adequate bronchodilator therapy. Patients also considered Turbuhaler and MDI equally effective, with a small preference for the MDI. Turbuhaler seems to be a valuable alternative to bronchodilator MDI therapy.
Osterman
K
K
Dept. of Lung Medicine, Karolinska Sjukhuset, Stockholm, Sweden.
Norborg
A M
AM
Stähl
E
E
D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D003258:Consumer Behavior; D004867:Equipment Design; D005260:Female; D006801:Humans; D008168:Lung / Q000502:physiology; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D011208:Powders; D011897:Random Allocation; D013726:Terbutaline / Q000008:administration & dosage* / Q000627:therapeutic use
D000336:Aerosols; D011208:Powders; D013726:Terbutaline